177 related articles for article (PubMed ID: 8099601)
1. Mode of action of the anti-AIDS compound poly(I).poly(C12U) (Ampligen): activator of 2',5'-oligoadenylate synthetase and double-stranded RNA-dependent kinase.
Ushijima H; Rytik PG; Schäcke H; Scheffer U; Müller WE; Schröder HC
J Interferon Res; 1993 Apr; 13(2):161-71. PubMed ID: 8099601
[TBL] [Abstract][Full Text] [Related]
2. 8-Azido double-stranded RNA photoaffinity probes. Enzymatic synthesis, characterization, and biological properties of poly(I,8-azidoI).poly(C) and poly(I,8-azidoI).poly(C12U) with 2',5'-oligoadenylate synthetase and protein kinase.
Li SW; Moskow JJ; Suhadolnik RJ
J Biol Chem; 1990 Apr; 265(10):5470-4. PubMed ID: 2318823
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of DNA topoisomerase I activity by 2',5'-oligoadenylates and mismatched double-stranded RNA in uninfected and HIV-1-infected H9 cells.
Schröder HC; Kelve M; Schäcke H; Pfleiderer W; Charubala R; Suhadolnik RJ; Müller WE
Chem Biol Interact; 1994 Feb; 90(2):169-83. PubMed ID: 8156606
[TBL] [Abstract][Full Text] [Related]
4. Biologic effects after a single dose of poly(I):poly(C12U) in healthy volunteers.
Hendrix CW; Margolick JB; Petty BG; Markham RB; Nerhood L; Farzadegan H; Ts'o PO; Lietman PS
Antimicrob Agents Chemother; 1993 Mar; 37(3):429-35. PubMed ID: 7681656
[TBL] [Abstract][Full Text] [Related]
5. Changes in the 2-5A synthetase/RNase L antiviral pathway in a controlled clinical trial with poly(I)-poly(C12U) in chronic fatigue syndrome.
Suhadolnik RJ; Reichenbach NL; Hitzges P; Adelson ME; Peterson DL; Cheney P; Salvato P; Thompson C; Loveless M; Müller WE
In Vivo; 1994; 8(4):599-604. PubMed ID: 7893988
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of the 2-5A synthetase/RNase L antiviral pathway associated with chronic fatigue syndrome.
Suhadolnik RJ; Reichenbach NL; Hitzges P; Sobol RW; Peterson DL; Henry B; Ablashi DV; Müller WE; Schröder HC; Carter WA
Clin Infect Dis; 1994 Jan; 18 Suppl 1():S96-104. PubMed ID: 8148461
[TBL] [Abstract][Full Text] [Related]
7. Mismatched double-stranded RNA, Ampligen (poly(I): poly(C12U), demonstrates antiviral and immunostimulatory activities in HIV disease.
Carter WA; Ventura D; Shapiro DE; Strayer DR; Gillespie DH; Hubbell HR
Int J Immunopharmacol; 1991; 13 Suppl 1():69-76. PubMed ID: 1688087
[TBL] [Abstract][Full Text] [Related]
8. Dose-related effects of Ampligen (poly(I).poly(C12U)), a mismatched double-stranded RNA, in a bleomycin-mouse model of pulmonary fibrosis.
Wild JS; Hyde DM; Hubbell HR; Giri SN
Exp Lung Res; 1996; 22(3):375-91. PubMed ID: 8792127
[TBL] [Abstract][Full Text] [Related]
9. Antiviral activity of mismatched double-stranded RNA against human immunodeficiency virus in vitro.
Montefiori DC; Mitchell WM
Proc Natl Acad Sci U S A; 1987 May; 84(9):2985-9. PubMed ID: 3106982
[TBL] [Abstract][Full Text] [Related]
10. The 2-5A system and HIV infection.
Schröder HC; Kelve M; Müller WE
Prog Mol Subcell Biol; 1994; 14():176-97. PubMed ID: 7914804
[TBL] [Abstract][Full Text] [Related]
11. [The dynamics of 2',5'-oligoadenylate synthetase activity in the nuclear and cytoplasmic fractions of human fibroblasts treated by double-stranded RNAs, by their complexes with DEAE-dextran and by type-I recombinant interferons. The ratio of double-stranded RNA-activated and -nonactivated froms of the enzyme].
Sokolova TM; Antonov AIu; Makhov AM
Antibiot Khimioter; 1991 Jun; 36(6):31-5. PubMed ID: 1898186
[TBL] [Abstract][Full Text] [Related]
12. Effects of varying lengths of double-stranded RNA on binding and activation of 2'-5'-oligoadenylate synthetase.
Desai SY; Sen GC
J Interferon Cytokine Res; 1997 Sep; 17(9):531-6. PubMed ID: 9335430
[TBL] [Abstract][Full Text] [Related]
13. Ampligen inhibits human herpesvirus-6 in vitro.
Ablashi DV; Berneman ZN; Williams M; Strayer DR; Kramarsky B; Suhadolnik RJ; Reichenbach N; Hiltzges P; Komaroff AL
In Vivo; 1994; 8(4):587-91. PubMed ID: 7893986
[TBL] [Abstract][Full Text] [Related]
14. The effects of poly(I).poly(C12U) and interferon on the multiplication of a mammalian type C retrovirus in human cells.
Chelbi-Alix MK; Belforte B; Saal F; Lasneret J; Peries J; Thang MN
J Gen Virol; 1992 Sep; 73 ( Pt 9)():2291-7. PubMed ID: 1383406
[TBL] [Abstract][Full Text] [Related]
15. Interferon-induced and double-stranded RNA-activated enzymes: a specific protein kinase and 2',5'-oligoadenylate synthetases.
Hovanessian AG
J Interferon Res; 1991 Aug; 11(4):199-205. PubMed ID: 1717615
[TBL] [Abstract][Full Text] [Related]
16. Mismatched double-stranded RNA: polyI:polyC12U.
Adis Editorial
Drugs R D; 2004; 5(5):297-304. PubMed ID: 15357629
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of the antiretroviral effect of dsRNA.
Müller WE; Ushijima H; Schröder HC
Prog Mol Subcell Biol; 1994; 14():66-88. PubMed ID: 7914807
[No Abstract] [Full Text] [Related]
18. Lymphocytic 2',5'-oligoadenylate synthetase is insensitive to dsRNA and interferon stimulation in autoimmune BB rats.
Bonnevie-Nielsen V; Husum G; Kristiansen K
J Interferon Res; 1991 Dec; 11(6):351-6. PubMed ID: 1800583
[TBL] [Abstract][Full Text] [Related]
19. Cellular and enzymatic activities of a synthetic heteropolymer double-stranded RNA of defined size.
Haines DS; Suhadolnik RJ; Hubbell HR; Gillespie DH
J Biol Chem; 1992 Sep; 267(26):18315-9. PubMed ID: 1356106
[TBL] [Abstract][Full Text] [Related]
20. A misaligned double-stranded RNA, poly(I).poly(C12,U), induces accumulation of 2',5'-oligoadenylates in mouse tissues.
Hearl WG; Johnston MI
Biochem Biophys Res Commun; 1986 Jul; 138(1):40-6. PubMed ID: 2427076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
